Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® Prevention specialty page provides infection prevention-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

PREVENTION NEWS - Page 1

Study Identifies Therapeutic Ranges for Cefepime and Neurotoxicity Risks
One of the biggest studies to-date on the relationship between cefepime plasma concentrations and neurotoxicity has identified which patients are at greatest risk.
Should Minors Be Able to Receive the MMR Vaccine Without Parental Consent?: Public Health Watch
Several states have or are considering laws that would circumvent consent from anti-vax parents.
HIV Vaccine Efficacy Trial Mosaico to Launch in Americas, Europe
Mosaico plans to register 3800 HIV-negative participants aged 18 to 60 years when enrollment opens later this year.
PrEP Use Among MSM Skyrockets 500% From 2014 to 2017
PrEP awareness among these MSM rose from 60% to 90% from 2014 to 2017, and PrEP use increased from 6% to 35%.
 
Trial Pairs PrEP With Behavioral Intervention to Prevent HIV in Drug Users
The program combines PrEP administration along with evidence-based behavioral intervention to reduce HIV risk behavior for HIV-negative, opioid-dependent people who use drugs and are receiving treatment.
Nearly Half of Daily PrEP Users Interested in Switching to On-Demand Dosing
Interest in on-demand HIV pre-exposure prophylaxis may be increasing, according to a survey in Australia.
PrEP Trials Offer Insight for Reaching at-Risk Women
Getting PrEP into the hands of those who stand to gain the most from it, including women in sub-Saharan Africa remains a challenge.
CDC Committee Votes to Expand HPV Vaccine Recommendations for Men Up to Age 26
ACIP voted 10-to-4 to expand the recommended HPV vaccine “catch-up” age for men from 21 to 26, matching the existing guidelines for women.
FEATURED
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?